Yong Sun
CIK 1592266 · View on SEC EDGAR ↗
First SEC filing: June 2, 2014 · Latest: June 2, 2014
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2019 | HBIO | F | 19,339 | $3.18 | $61,498 | 242,805 Direct | -7.38% | Disposed | -77.4% (price as of 2026-08-20) |
| Aug. 14, 2018 | HBIO | M | 50,000 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Aug. 14, 2018 | HBIO | F | 37,588 | $6.65 | $249,960 | 262,144 Direct | -12.54% | Disposed | -89.2% (price as of 2026-08-20) |
| Aug. 14, 2018 | HBIO | M | 50,000 | $4.31 | $215,500 | 299,732 Direct | +20.02% | Acquired | -83.3% (price as of 2026-08-20) |
| Aug. 3, 2018 | HBIO | F | 2,043 | $5.70 | $11,645 | 249,732 Direct | -0.81% | Disposed | -87.4% (price as of 2026-08-20) |
| Aug. 1, 2018 | HBIO | M | 50,000 | — | — | 50,000 Direct | -50.00% | Disposed | (price as of 2026-08-20) |
| Aug. 1, 2018 | HBIO | F | 41,054 | $5.75 | $236,060 | 258,804 Direct | -13.69% | Disposed | -87.5% (price as of 2026-08-20) |
| Aug. 1, 2018 | HBIO | M | 50,000 | $4.31 | $215,500 | 299,858 Direct | +20.01% | Acquired | -83.3% (price as of 2026-08-20) |
| May 24, 2018 | HBIO | A | 22,500 | — | — | 249,858 Direct | +9.90% | Acquired | (price as of 2026-08-20) |
| May 24, 2018 | HBIO | A | 22,500 | — | — | 227,358 Direct | +10.98% | Acquired | (price as of 2026-08-20) |
| March 8, 2018 | HBIO | A | 8,888 | — | — | 207,397 Direct | +4.48% | Acquired | (price as of 2026-08-20) |
| March 8, 2018 | HBIO | F | 2,539 | $4.50 | $11,426 | 204,858 Direct | -1.22% | Disposed | -84.0% (price as of 2026-08-20) |
| Jan. 1, 2018 | HBIO | F | 19,378 | $3.30 | $63,947 | 198,509 Direct | -8.89% | Disposed | -78.2% (price as of 2026-08-20) |
| May 25, 2017 | HBIO | A | 109,130 | — | — | 217,887 Direct | +100.34% | Acquired | (price as of 2026-08-20) |
| Feb. 6, 2017 | HBIO | A | 10,000 | — | — | 10,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 1, 2017 | HBIO | F | 9,922 | $3.05 | $30,262 | 108,757 Direct | -8.36% | Disposed | -76.4% (price as of 2026-08-20) |
| May 6, 2016 | HBIO | A | 89,007 | — | — | 118,681 Direct | +299.95% | Acquired | (price as of 2026-08-20) |
| Jan. 1, 2016 | HBIO | F | 1,609 | $3.47 | $5,583 | 29,674 Direct | -5.14% | Disposed | -79.3% (price as of 2026-08-20) |
| Aug. 3, 2015 | HBIO | A | 14,058 | — | — | 31,283 Direct | +81.61% | Acquired | (price as of 2026-08-20) |
| June 4, 2015 | HBIO | A | 32,500 | — | — | 32,500 Direct | — | Acquired | (price as of 2026-08-20) |
| June 4, 2015 | HBIO | A | 17,225 | — | — | 17,225 Direct | — | Acquired | (price as of 2026-08-20) |
| May 30, 2014 | HBIO | A | 35,000 | — | — | 35,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Nov. 18, 2013 | HBIO | A | 100,000 | — | — | 100,000 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 14, 2018 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (100,000) | $4.31 | Nov. 18, 2023 | 50,000 | Disposed |
| Aug. 1, 2018 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (100,000) | $4.31 | Nov. 18, 2023 | 50,000 | Disposed |
| Feb. 6, 2017 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (10,000) | $3.25 | Feb. 6, 2027 | 10,000 | Acquired |
| June 4, 2015 | HBIO | Common Stock, par value $0.01 per share | Common Stock, par value $0.01 per share (32,500) | $5.56 | June 4, 2025 | 32,500 | Acquired |
| May 30, 2014 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (35,000) | $4.12 | May 30, 2024 | 35,000 | Acquired |
| Nov. 18, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (100,000) | $4.31 | Nov. 18, 2023 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $254,911 | — | — | — | — | — | $11,181 | $460,492 |
| 2017 | $247,457 | $24,880 | — | $12,700 | — | — | $49,898 | $545,938 |
| 2016 | $240,442 | — | — | — | — | — | $9,610 | $501,052 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.